In clinical literature, the underlying phenomenon relates to how appetite-regulating hormones - particularly GLP-1, ghrelin, and leptin - interact with reward and satiety pathways in the brain
However, researchers should note that longer trials with ipamorelin may cause side effects typical for ghrelin mimetics, such as water retention and increased appetite [23]
Ozempic, Saxenda and Wegovy: all three are name brands for the generic drug Semaglutide, which simulates the activity of the protein GLP-1 that is naturally present in the human body
Novartis completed its shift to a pure innovative medicines model in 2025, with Entresto (~$7B+) and Kesimpta driving top-10 global pharma revenue ranking post-Sandoz spin-off
The medication is clinically identical in mechanism: it activates the GLP-1 and GIP receptors in the brain to reduce appetite and stabilize blood sugar
main effect P = 0.097), while IGF-1 levels in males were unaffected by treatment or age in this strain (Fig